{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:48:41Z","timestamp":1783698521910,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Eat Disord"],"DOI":"10.1186\/s40337-025-01232-y","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:25:41Z","timestamp":1742228741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ketamine as adjuvant treatment in eating disorders: an exploratory study of a case series and retrospective analysis"],"prefix":"10.1186","volume":"13","author":[{"given":"Paula J.","family":"Escobedo-Aedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Serrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mentine","family":"Estric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"1232_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association., American Psychiatric Association. DSM-5 task force. Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association. 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"1232_CR2","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/ajcn\/nqy342","volume":"109","author":"M Galmiche","year":"2019","unstructured":"Galmiche M, D\u00e9chelotte P, Lambert G, Tavolacci MP. Prevalence of eating disorders over the 2000\u20132018 period: a systematic literature review. Am J Clin Nutr. 2019;109:1402\u201313.","journal-title":"Am J Clin Nutr"},{"key":"1232_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and National burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Psychiatry. 2022;9:137\u201350.","journal-title":"Lancet Psychiatry"},{"key":"1232_CR4","doi-asserted-by":"crossref","unstructured":"Sideli L, Lo Coco G, Bonfanti RC, Borsarini B, Fortunato L, Sechi C et al. Effects of COVID-19 lockdown on eating disorders and obesity: A systematic review and meta-analysis. European Eating Disorders Review. John Wiley and Sons Ltd. 2021. pp. 826\u201341.","DOI":"10.1002\/erv.2861"},{"key":"1232_CR5","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/eat.23318","volume":"53","author":"RF Rodgers","year":"2020","unstructured":"Rodgers RF, Lombardo C, Cerolini S, Franko DL, Omori M, Fuller-Tyszkiewicz M, et al. The impact of the COVID-19 pandemic on eating disorder risk and symptoms. Int J Eat Disord. 2020;53:1166\u201370.","journal-title":"Int J Eat Disord"},{"key":"1232_CR6","doi-asserted-by":"publisher","unstructured":"Taquet M, Geddes JR, Luciano S, Harrison PJ. Incidence and outcomes of eating disorders during the COVID-19 pandemic. 2022. Available from: https:\/\/doi.org\/10.1192\/bjp.2021","DOI":"10.1192\/bjp.2021"},{"key":"1232_CR7","doi-asserted-by":"crossref","unstructured":"Himmerich H, Keeler JL, Tchanturia K, Treasure J. Treatment escalation for people with anorexia nervosa: setting, therapies and nutritional interventions. Curr Opin Psychiatry. 2024;37;6:404-16","DOI":"10.1097\/YCO.0000000000000964"},{"key":"1232_CR8","doi-asserted-by":"crossref","unstructured":"Blanchet C, Guillaume S, Bat-Pitault F, Carles ME, Clarke J, Dodin V et al. Medication in AN: A multidisciplinary overview of meta-analyses and systematic reviews. J Clin Med. MDPI. 2019.","DOI":"10.3390\/jcm8020278"},{"key":"1232_CR9","doi-asserted-by":"crossref","unstructured":"Kotilahti E, West M, Isomaa R, Karhunen L, Rocks T, Ruusunen A. Treatment interventions for Severe and Enduring Eating Disorders: Systematic review. International Journal of Eating Disorders. John Wiley and Sons Inc. 2020. pp. 1280\u2013302.","DOI":"10.1002\/eat.23322"},{"key":"1232_CR10","doi-asserted-by":"crossref","unstructured":"Calder A, Mock S, Friedli N, Pasi P, Hasler G. Psychedelics in the treatment of eating disorders: rationale and potential mechanisms. European neuropsychopharmacology. Elsevier B.V. 2023. pp. 1\u201314.","DOI":"10.1016\/j.euroneuro.2023.05.008"},{"key":"1232_CR11","doi-asserted-by":"crossref","unstructured":"Goodwin-Groen S, Dong Y, Aoki C. Three daily intraperitoneal injections of sub-anesthetic ketamine ameliorate activity-based anorexia vulnerability of adult female mice. Int J Eat Disord. 2023;57;7:1447\u201364.","DOI":"10.1002\/eat.24036"},{"key":"1232_CR12","doi-asserted-by":"crossref","unstructured":"Aoki C, Santiago AN. Pathway-specific GABAergic Inhibition contributes to the gain of resilience against anorexia-like behavior of adolescent female mice. Front Behav Neurosci. 2022;16.","DOI":"10.3389\/fnbeh.2022.990354"},{"key":"1232_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00429-023-02740-w","volume":"229","author":"J Li","year":"2024","unstructured":"Li J, Temizer R, Chen YW, Aoki C. Ketamine ameliorates activity-based anorexia of adolescent female mice through changes in GluN2B-containing NMDA receptors at postsynaptic cytoplasmic locations of pyramidal neurons and interneurons of medial prefrontal cortex. Brain Struct Funct. 2024;229:323\u201348.","journal-title":"Brain Struct Funct"},{"key":"1232_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/brainsci12030382","volume":"12","author":"A Ragnhildstveit","year":"2022","unstructured":"Ragnhildstveit A, Slayton M, Jackson LK, Brendle M, Ahuja S, Holle W, et al. Ketamine as a novel psychopharmacotherapy for eating disorders: evidence and future directions. Brain Sci. 2022;12:382.","journal-title":"Brain Sci"},{"key":"1232_CR15","doi-asserted-by":"crossref","unstructured":"Walsh Z, Mollaahmetoglu OM, Rootman J, Golsof S, Keeler J, Marsh B et al. Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review. BJPsych Open. 2022;8.","DOI":"10.1192\/bjo.2022.5"},{"key":"1232_CR16","doi-asserted-by":"crossref","unstructured":"Jelen LA, Young AH, Stone JM, Ketamine. A tale of two enantiomers. Journal of Psychopharmacology. SAGE Publications Ltd. 2021. pp. 109\u201323.","DOI":"10.1177\/0269881120959644"},{"key":"1232_CR17","doi-asserted-by":"crossref","unstructured":"Matveychuk D, Thomas RK, Swainson J, Khullar A, MacKay MA, Baker GB et al. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers. Ther Adv Psychopharmacol. 2020;10.","DOI":"10.1177\/2045125320916657"},{"key":"1232_CR18","doi-asserted-by":"publisher","first-page":"11158","DOI":"10.1523\/JNEUROSCI.1547-16.2016","volume":"36","author":"CF Zorumski","year":"2016","unstructured":"Zorumski CF, Izumi Y, Mennerick S. Ketamine: NMDA receptors and beyond. J Neurosci. 2016;36:11158\u201364.","journal-title":"J Neurosci"},{"key":"1232_CR19","doi-asserted-by":"crossref","unstructured":"Zhang B, Yang X, Ye L, Liu R, Ye B, Du W et al. Ketamine activated glutamatergic neurotransmission by GABAergic disinhibition in the medial prefrontal cortex. Neuropharmacology. 2021;194.","DOI":"10.1016\/j.neuropharm.2020.108382"},{"key":"1232_CR20","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","volume":"388","author":"A Anand","year":"2023","unstructured":"Anand A, Mathew SJ, Sanacora G, Murrough JW, Goes FS, Altinay M, et al. Ketamine versus ECT for nonpsychotic Treatment-Resistant major depression. N Engl J Med. 2023;388:2315\u201325.","journal-title":"N Engl J Med"},{"key":"1232_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","volume":"173","author":"JB Singh","year":"2016","unstructured":"Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, et al. A Double-Blind, randomized, Placebo-Controlled, Dose-Frequency study of intravenous ketamine in patients with Treatment-Resistant depression. Am J Psychiatry. 2016;173:816\u201326.","journal-title":"Am J Psychiatry"},{"key":"1232_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","volume":"178","author":"RS McIntyre","year":"2021","unstructured":"McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, et al. Synthesizing the evidence for ketamine and Esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178:383\u201399.","journal-title":"Am J Psychiatry"},{"key":"1232_CR23","doi-asserted-by":"crossref","unstructured":"Fountoulakis KN, Saitis A, Schatzberg AF. Esketamine treatment for depression in adults: A PRISMA systematic review and Meta-Analysis. Am J Psychiatry. 2025;182;3:259\u201375.","DOI":"10.1176\/appi.ajp.20240515"},{"key":"1232_CR24","doi-asserted-by":"publisher","first-page":"204512532110567","DOI":"10.1177\/20451253211056743","volume":"11","author":"E Whittaker","year":"2021","unstructured":"Whittaker E, Dadabayev AR, Joshi SA, Glue P. Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders. Ther Adv Psychopharmacol. 2021;11:204512532110567.","journal-title":"Ther Adv Psychopharmacol"},{"key":"1232_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/HRP.0000000000000330","volume":"30","author":"ID Bandeira","year":"2022","unstructured":"Bandeira ID, Lins-Silva DH, Cavenaghi VB, Dorea-Bandeira I, Faria-Guimar\u00e3es D, Barouh JL, et al. Ketamine in the treatment of Obsessive-Compulsive disorder: A systematic review. Harv Rev Psychiatry. 2022;30:135\u201345.","journal-title":"Harv Rev Psychiatry"},{"key":"1232_CR26","unstructured":"Mills IH, Park1 GR, Manara1 AR, Merriman RJ. Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions. Q J Med. 1998."},{"key":"1232_CR27","doi-asserted-by":"crossref","unstructured":"Schwartz T, Trunko ME, Feifel D, Lopez E, Peterson D, Frank GKW et al. A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment-resistant depression. Clin Case Rep. 2021;9.","DOI":"10.1002\/ccr3.3869"},{"key":"1232_CR28","doi-asserted-by":"crossref","unstructured":"Ragnhildstveit A, Jackson LK, Cunningham S, Good L, Tanner Q, Roughan M et al. Case report: unexpected remission from extreme and enduring bulimia nervosa with repeated ketamine assisted psychotherapy. Front Psychiatry. 2021;12.","DOI":"10.3389\/fpsyt.2021.764112"},{"key":"1232_CR29","doi-asserted-by":"crossref","unstructured":"Scolnick B, Zupec-Kania B, Calabrese L, Aoki C, Hildebrandt T. Remission from chronic anorexia nervosa with ketogenic diet and ketamine: case report. Front Psychiatry. 2020;11.","DOI":"10.3389\/fpsyt.2020.00763"},{"key":"1232_CR30","doi-asserted-by":"crossref","unstructured":"Robison R, Lafrance A, Brendle M, Smith M, Moore C, Ahuja S et al. A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders. J Eat Disord. 2022;10.","DOI":"10.1186\/s40337-022-00588-9"},{"key":"1232_CR31","doi-asserted-by":"crossref","unstructured":"Marcolini F, Ravaglia A, Tempia Valenta S, Bosco G, Marconi G, De Ronchi D et al. Severe enduring anorexia nervosa (SE-AN) treatment options and their effectiveness: a review of literature. J Eat Disord. BioMed Central Ltd. 2024.","DOI":"10.1186\/s40337-024-01006-y"},{"key":"1232_CR32","doi-asserted-by":"crossref","unstructured":"Kirchberg MC, Pinson C, Frank GKW. Pharmacotherapeutic strategies for the treatment of anorexia nervosa\u2013novel targets to break a vicious cycle. Expert Opin Pharmacother. Taylor and Francis Ltd. 2024.","DOI":"10.1080\/14656566.2024.2424316"},{"key":"1232_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/eip.12170","volume":"9","author":"J Treasure","year":"2015","unstructured":"Treasure J, Stein D, Maguire S. Has the time come for a staging model to map the course of eating disorders from high risk to severe enduring illness? An examination of the evidence. Early Interv Psychiatry. 2015;9:173\u201384.","journal-title":"Early Interv Psychiatry"},{"key":"1232_CR34","doi-asserted-by":"publisher","first-page":"9350","DOI":"10.12998\/wjcc.v9.i31.9350","volume":"9","author":"R Karrouri","year":"2021","unstructured":"Karrouri R, Hammani Z, Otheman Y, Benjelloun R. Major depressive disorder: validated treatments and future challenges. World J Clin Cases. 2021;9:9350\u201367.","journal-title":"World J Clin Cases"},{"key":"1232_CR35","doi-asserted-by":"crossref","unstructured":"Abbar M, Demattei C, El-Hage W, Llorca P-M, Samalin L, Demaricourt P et al. Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial. BMJ. 2022;376:e067194.","DOI":"10.1136\/bmj-2021-067194"},{"key":"1232_CR36","doi-asserted-by":"crossref","unstructured":"Stahl SM. Stahl\u2019s essential psychopharmacology. Cambridge University Press; 2021.","DOI":"10.1017\/9781108975292"},{"key":"1232_CR37","doi-asserted-by":"crossref","unstructured":"Keeler JL, Treasure J, Juruena MF, Kan C, Himmerich H. Ketamine as a treatment for anorexia nervosa: A narrative review. Nutrients. MDPI; 2021.","DOI":"10.3390\/nu13114158"},{"key":"1232_CR38","doi-asserted-by":"publisher","unstructured":"Nikkheslat N. Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency. Brain Behav Immun Health [Internet]. 2021 [cited 2022 Feb 14];18:100383. Available from: https:\/\/doi.org\/10.1016\/j.bbih.2021.100383","DOI":"10.1016\/j.bbih.2021.100383"},{"key":"1232_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jpsychires.2018.06.002","volume":"103","author":"B Dalton","year":"2018","unstructured":"Dalton B, Bartholdy S, Robinson L, Solmi M, Ibrahim MAA, Breen G, et al. A meta-analysis of cytokine concentrations in eating disorders. J Psychiatr Res. 2018;103:252\u201364.","journal-title":"J Psychiatr Res"},{"key":"1232_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00213-010-2121-3","volume":"215","author":"V Ricci","year":"2011","unstructured":"Ricci V, Martinotti G, Gelfo F, Tonioni F, Caltagirone C, Bria P, et al. Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. Psychopharmacology. 2011;215:143\u20138.","journal-title":"Psychopharmacology"},{"key":"1232_CR41","doi-asserted-by":"crossref","unstructured":"Deyama S, Duman RS. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Pharmacol Biochem Behav. Elsevier Inc. 2020.","DOI":"10.1016\/j.pbb.2019.172837"},{"key":"1232_CR42","doi-asserted-by":"crossref","unstructured":"Calder AE, Hase A, Hasler G. Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis. Mol Psychiatry. Springer Nature. 2024.","DOI":"10.1038\/s41380-024-02830-z"},{"key":"1232_CR43","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1007\/s40519-022-01455-x","volume":"27","author":"L Calabrese","year":"2022","unstructured":"Calabrese L, Scolnick B, Zupec-Kania B, Beckwith C, Costello K, Frank GKW. Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study. Eat Weight Disorders. 2022;27:3751\u20137.","journal-title":"Eat Weight Disorders"},{"key":"1232_CR44","doi-asserted-by":"crossref","unstructured":"Hermens DF, Simcock G, Dutton M, Bou\u00e7as AP, Can AT, Lilley C, et al. Anorexia nervosa, zinc deficiency and the glutamate system: the ketamine option. Prog neuropsychopharmacol biol psychiatry. Elsevier Inc. 2020;101:109921.","DOI":"10.1016\/j.pnpbp.2020.109921"},{"key":"1232_CR45","doi-asserted-by":"crossref","unstructured":"Mitchell JS, Hermens DF, Bennett MR, Can AT, Lagopoulos J. Ketamine and zinc: treatment of anorexia nervosa via dual NMDA receptor modulation. CNS Drugs. Adis. 2023. pp. 159\u201380.","DOI":"10.1007\/s40263-022-00984-4"},{"key":"1232_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/erv.2885","volume":"30","author":"S Giles","year":"2022","unstructured":"Giles S, Hughes EK, Fuller-Tyszkiewicz M, Treasure J, Fernandez\u2010Aranda F, Karwautz AFK, et al. Bridging of childhood obsessive\u2010compulsive personality disorder traits and adult eating disorder symptoms: A network analysis approach. Eur Eat Disorders Rev. 2022;30:110\u201323.","journal-title":"Eur Eat Disorders Rev"},{"key":"1232_CR47","doi-asserted-by":"publisher","first-page":"105410","DOI":"10.1016\/j.neubiorev.2023.105410","volume":"154","author":"H Bottemanne","year":"2023","unstructured":"Bottemanne H, Berkovitch L, Gauld C, Balcerac A, Schmidt L, Mouchabac S, et al. Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect. Neurosci Biobehav Rev. 2023;154:105410.","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Journal of Eating Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-025-01232-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40337-025-01232-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-025-01232-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:25:50Z","timestamp":1742228750000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeatdisord.biomedcentral.com\/articles\/10.1186\/s40337-025-01232-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1186\/s40337-025-01232-y","relation":{},"ISSN":["2050-2974"],"issn-type":[{"value":"2050-2974","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For minor patients, both parents or guardians and patients were informed and accepted the treatment. The study was approved by the local Institutional Review Board (#23.12.05).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants agreed to the publication of their information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}